pcn poster

Posters

Healthcare Providers` Perspectives on Diagnosing and Treating Adults With Attention Deficit/Hyperactivity Disorder (ADHD)

This poster was presented at the 30th annual  Psych Congress, held Sept. 16-19, 2017, in New Orleans, Louisiana. Objectives: To understand diagnosis/treatment patterns of adult ADHD...

12/21/2017

Goal Attainment Scaling as a Metric for Treatment Effectiveness for Patients With Major Depressive Disorder: Attitudes on Goals in Depression

This poster was presented at the 30th annual  Psych Congress, held Sept. 16-19, 2017, in New Orleans, Louisiana.

12/21/2017

Exposure-Response (E-R) of Lurasidone in Pediatric Patients With Bipolar Depression: Simulation and Comparison to Adults

This poster was presented at the 30th annual  Psych Congress, held Sept. 16-19, 2017, in New Orleans, Louisiana. Objective: To evaluate the consistency of the E-R relationship of lu...

12/21/2017

Evaluation of Potential Drug Interactions With Valbenazine

  This poster was presented at the 30th annual  Psych Congress, held Sept. 16-19, 2017, in New Orleans, Louisiana. Background: Potential pharmacokinetic interactions between v...

12/15/2017

Efficacy and Safety of Lurasidone in Children and Adolescent Patients With Bipolar I Depression

  This poster was presented at the 30th annual  Psych Congress, held Sept. 16-19, 2017, in New Orleans, Louisiana. Objective: To evaluate the efficacy and safety of lurasidone...

12/15/2017

Efficacy and Safety of Lurasidone in Bipolar Depression: Treatment Review

  This poster was presented at the 30th annual  Psych Congress, held Sept. 16-19, 2017, in New Orleans, Louisiana. Objective: To review safety and efficacy data on lurasidone ...

12/15/2017

Efficacy and Safety of Flexibly-Dosed Brexpiprazole for the Adjunctive Treatment of Major Depressive Disorder: A Randomized, Active-Referenced, Placebo-Controlled Study

  This poster was presented at the 30th annual  Psych Congress, held Sept. 16-19, 2017, in New Orleans, Louisiana. Background: The efficacy and safety of brexpiprazole as adju...

12/15/2017

Effects of SHP465 Mixed Amphetamine Salts Extended-Release on Patient Global Functioning and Vital Signs in Adults With Attention-Deficit/Hyperactivity Disorder

  This poster was presented at the 30th annual  Psych Congress, held Sept. 16-19, 2017, in New Orleans, Louisiana.

12/15/2017

Effects of Food on the Bioavailability of Amphetamine in Healthy Adults After Administration of SHP465 Mixed Amphetamine Salts Extended-Release

  This poster was presented at the 30th annual  Psych Congress, held Sept. 16-19, 2017, in New Orleans, Louisiana.

12/15/2017

Effects of Adjunctive Brexpiprazole on Chronobiologic Parameters in Patients With Major Depressive Disorder and Sleep Disturbances

  This poster was presented at the 30th annual  Psych Congress, held Sept. 16-19, 2017, in New Orleans, Louisiana.

12/15/2017

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

Rapid Refresh

Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics

04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP, and...

Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...

Andrew Penn, MS, PMHNP, and...

04/11/2024

Psych Congress NP Institute

Rapid Refresh

Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder

04/10/2024

Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...

Amber Hoberg, PMHNP-BC,...

04/10/2024

Psych Congress NP Institute

Clinical Pearls

Tolerability Testing in Long-Acting Injectable Prescriptions

04/03/2024

Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.

Posters

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

Sign Up

Specialties

Events

Year Round Education

HMP Global Products